← Leaderboards
Nathalie Bergeron
Children'S Hospital & Res Ctr At Oakland
$4,314,948
Attributed
$8,629,896
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2009–15$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$8,629,896 · 2
By mechanism
R01$7,630,326 · 1
RC1$999,570 · 1
Top collaborators
- Ronald M Krauss9 shared
Others in their field
Top investigators on “Metabolic”
- David M Nathan · Massachusetts Institute Of Technology$157,845,616
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$144,157,234
- Judith S. Currier · University Of California Los Angeles$141,260,706
- John M Lachin · George Washington University$139,991,329
- Randall J Bateman · Washington University$124,168,384
- Carol Nesel · Westat$116,355,411
Research focus
MetabolicSaturated FatHeparinLow-Density LipoproteinsPlasmaRegulationGuidelinesCardiovascular Disorder RiskIntakeLipoproteinsDyslipidemiasParticleRandomizedRecommendationFatty Acid Glycerol EstersFoodCardiovascular DiseasesCarbohydratesHepatic LipaseInsulin SensitivityLdl Cholesterol LipoproteinsLipidsDietSource
Grant awards (9)
Saturated Fat and Protein Effects on Atherogenic Dyslipidemia$1,387,413
R01 · FY2015 · HL
Saturated Fat and Protein Effects on Atherogenic Dyslipidemia$1,475,328
R01 · FY2014 · HL
Saturated Fat and Protein Effects on Atherogenic Dyslipidemia$169,697
R01 · FY2014 · HL
Saturated Fat and Protein Effects on Atherogenic Dyslipidemia$1,436,341
R01 · FY2013 · HL
Saturated Fat and Protein Effects on Atherogenic Dyslipidemia$1,504,126
R01 · FY2012 · HL
Saturated Fat and Protein Effects on Atherogenic Dyslipidemia$200,000
R01 · FY2012 · HL
Saturated Fat and Protein Effects on Atherogenic Dyslipidemia$1,457,421
R01 · FY2011 · HL
Effects of resistant starch on lipid and glucose metabolism in insulin resistance$469,824
RC1 · FY2010 · DK
Effects of resistant starch on lipid and glucose metabolism in insulin resistance$529,746
RC1 · FY2009 · DK